Pramod K Giri
Affiliation: University of Notre Dame
- Is intranasal vaccination a feasible solution for tuberculosis?Pramod K Giri
Postdoctoral Research Associate, Eck Center for Global Health and Infectious Disease, Dept of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA
Expert Rev Vaccines 7:1341-56. 2008..This article will focus on the potential of intranasal vaccination and mucosal adjuvants for the development of new-generation TB vaccines...
- How could we have better vaccines against tuberculosis?Pramod K Giri
University of Notre Dame, Eck Center for Global Health and Infectious Disease, Department of Biological Sciences, Notre Dame, IN 46556, USA
Expert Opin Biol Ther 8:1759-72. 2008..One-third of the world's population is now infected with the TB bacillus. According to the WHO, an estimated 1.7 million people died from TB in 2006. More precisely, every 15 seconds, one person dies due to TB worldwide...
- Adjunct immunotherapy with Ag85 complex proteins based subunit vaccine in a murine model of Mycobacterium tuberculosis infectionPramod K Giri
University of Notre Dame, IN, USA
Immunotherapy 1:31-7. 2009..In conclusion, this study shows that Ag85AB-CpG-DDA formulation may act as a potential future therapeutic regimen in conjunction with antituberculous drugs...